株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

幹細胞・再生療法の世界市場

Global Stem Cell and Regenerative Therapy Market: A BCC Research Outlook

発行 BCC Research 商品コード 877640
出版日 ページ情報 英文 189 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.90円で換算しております。
Back to Top
幹細胞・再生療法の世界市場 Global Stem Cell and Regenerative Therapy Market: A BCC Research Outlook
出版日: 2019年06月25日 ページ情報: 英文 189 Pages
概要

世界の幹細胞・再生医療市場は、2019年の218億米ドルから、2024年までに550億米ドルまで拡大すると見られています。市場は、2019年~2024年のCAGR (複合年間成長率) で、20.4%の成長が予測されています。

当レポートでは、世界の幹細胞・再生医療市場について調査分析し、市場の概要、市場動向の分析と予測、胚性幹細胞 (ES細胞) ・成体幹細胞の歴史的な背景と説明、幹細胞バンク・幹細胞研究に関する情報、再生医療におけるR&D活動の調査、および主要企業のプロファイルなどを提供しています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 幹細胞・再生療法の市場・技術背景

  • 概要:細胞
  • 概要:幹細胞
  • 胚性幹細胞 (ES細胞)
  • 成体幹細胞
  • 間葉幹細胞
  • 造血幹細胞
  • 神経幹細胞
  • 内皮前駆細胞
  • 上皮幹細胞
  • 極小胚様幹
  • 臍帯血幹細胞
  • 誘導多能性幹細胞 (iPS細胞)
  • 幹細胞における細胞リプログラミング
  • ヒト単為発生幹細胞
  • 幹細胞・再生療法における制限
  • がん幹細胞
  • 幹細胞生物学の歴史的な背景
  • 幹細胞研究
  • 幹細胞の生産
  • 個別治療
  • 概要:再生医療

第4章 市場力学

  • 市場成長の促進要因
  • 市場成長の抑制要因

第5章 幹細胞・再生療法市場の分析:製品別

  • 世界の幹細胞・再生医療市場:製品別
  • 治療製品
  • 細胞バンク
  • ツール・試薬

第6章 幹細胞・再生療法市場の分析:用途別

  • 世界の幹細胞・再生医療市場:用途別
  • 心血管疾患
  • 皮膚科
  • 整形外科
  • 中枢神経系疾患
  • 糖尿病
  • その他

第7章 幹細胞・再生療法市場の分析:地域別

  • 世界の幹細胞・再生医療市場:地域別
  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第8章 規制シナリオ

  • 幹細胞の規制

第9章 特許分析

  • 特許分析
  • ティッシュエンジニアリング・再生関連特許
  • 幹細胞特許

第10章 競合情勢

第11章 企業プロファイル

第12章 付録:略語

図表

List of Tables

  • Summary Table: Global Stem Cell and Regenerative Medicines Market, by Region, Through 2024
    • Table 1: Investments in Stem Cell Research
    • Table 2: Snapshot of Regenerative Product Pipeline
    • Table 3: Ethical Issues in Different Phases of Stem Cell Research
    • Table 4: Global Stem Cell and Regenerative Medicines Market, by Product, Through 2024
    • Table 5: Global Stem Cell and Regenerative Therapeutic Products Market, byType, Through 2024
    • Table 6: Cell-Based Immunotherapy Products
    • Table 7: Stem Cells, Advantages and Clinical Trials in Cardiovascular Disease Treatment
    • Table 8: Tissue-Engineered Products
    • Table 9: Clinical Trials of Rare Diseases, by Technology, 2018
    • Table 10: Gene Therapy Products
    • Table 11: Recent Developments in the Stem Cell Reagents, 2016-2019
    • Table 12: Global Stem Cell and Regenerative Medicines Market, by Application, Through 2024
    • Table 13: Cell Therapies by Different Companies to Treat Cardiovascular Diseases
    • Table 14: Global and U.S. Statistics for Skin Damage Medical Conditions, 2018
    • Table 15: Cellular Skin Tissue-Engineered Products in the Market
    • Table 16: Orthopedic Diseases by Region: Key Facts
    • Table 17: Demineralized Bone Matrix Products Cleared by FDA
    • Table 18: Global Stem Cell and Regenerative Medicines Market, by Region, Through 2024
    • Table 19: Regenerative Medicine Companies, by Size and Region, 2018
    • Table 20: North American Stem Cell and Regenerative Medicines Market, by Country, Through 2024
    • Table 21: European Stem Cell and Regenerative Medicines Market, by Country, Through 2024
    • Table 22: Asia-Pacific Stem Cell and Regenerative Medicines Market, by Country, Through 2024
    • Table 23: Regenerative Medical Products Approved in Japan Since the New Regenerative Medicine Legislation
    • Table 24: Japan Tissue Engineering and Regeneration Technologies Patents, 2016-February 2019
    • Table 25: Europe Tissue Engineering and Regeneration Technologies Patents, 2016-February 2019
    • Table 26: U.S. Tissue Engineering and Regeneration Technologies Patents, 2016-February 2019
    • Table 27: Abbreviations Used in This Report

List of Figures

  • Summary Figure: Global Stem Cell and Regenerative Medicines Market Share, by Region, 2018
    • Figure 1: Early Development of Embryo
    • Figure 2: Global Stem Cell and Regenerative Medicines Market Share, by Product, 2018
    • Figure 3: Global Stem Cell and Regenerative Therapeutic Products Market, 2018-2024
    • Figure 4: Global Stem Cell and Regenerative Therapeutic Products Market Share, by Type, 2018
    • Figure 5: Global Cell Therapy Market, 2018-2024
    • Figure 6: Global Tissue Engineering Market, 2018-2024
    • Figure 7: Global Prevalence of Diabetes, by Region, 2017
    • Figure 8: Global Gene Therapy Market, 2018-2024
    • Figure 9: Global Cell Banking Market, 2018-2024
    • Figure 10: Global Tools and Reagents Market, 2018-2024
    • Figure 11: Global Stem Cell and Regenerative Medicines Market Share, by Application, 2018
    • Figure 12: Global Stem Cell and Regenerative Medicines Market for Oncology, 2018-2024
    • Figure 13: T-cell Therapy Technique
    • Figure 14: Global Segmentation for Cancer Stem Cells Market
    • Figure 15: Global Stem Cell and Regenerative Medicines Market for Cardiovascular Disorders, 2018-2024
    • Figure 16: Global Stem Cell and Regenerative Medicines Market for Dermatology, 2018-2024
    • Figure 17: Global Stem Cell and Regenerative Medicines Market for Orthopedics, 2018-2024
    • Figure 18: Global Number of Surgeries, 2012-2020
    • Figure 19: Global Stem Cell and Regenerative Medicines Market for Central Nervous System Disorders, 2018-2024
    • Figure 20: Global Stem Cell and Regenerative Medicines Market for Diabetes, 2018-2024
    • Figure 21: Global Stem Cell and Regenerative Medicines Market for Other Applications, 2018-2024
    • Figure 22: Global Stem Cell and Regenerative Medicines Market Share, by Region, 2018
    • Figure 23: Regenerative Medicine Companies, by Size and Region, 2018
    • Figure 24: North American Stem Cell and Regenerative Medicines Market Share, by Country, 2018
    • Figure 25: U.S. Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 26: Potential U.S. Patient Populations for Cell-Based Therapies, 2016
    • Figure 27: NIH Stem Cell Research Spending, 2013-2018
    • Figure 28: Canadian Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 29: Mexican Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 30: European Stem Cell and Regenerative Medicines Market Share, by Country, 2018
    • Figure 31: German Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 32: Health Spending Throughout Germany, by Source, 2015 and 2040 (Est.)
    • Figure 33: U.K. Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 34: French Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 35: Italian Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 36: Spanish Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 37: Rest of Europe Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 38: Asia-Pacific Stem Cell and Regenerative Medicines Market Share, by Country, 2018
    • Figure 39: Japanese Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 40: Chinese Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 41: Indian Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 42: Rest of Asia-Pacific Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 43: South American Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 44: Middle East and African Stem Cell and Regenerative Medicines Market, 2018-2024
    • Figure 45: Factors Driving M&A Deals Across the Life Science Sector
目次
Product Code: BIO191A

Report Highlights:

The global stem cell and regenerative medicines market should grow from $21.8 billion in 2019 to reach $55.0 billion by 2024 at a compound annual growth rate (CAGR) of 20.4% for the period of 2019-2024.

North American market for stem cell and regenerative medicines should grow from $9.4 billion in 2019 to reach $23.5 billion by 2024 at a CAGR of 20.3% for the period of 2019-2024.

Asia-Pacific market for stem cell and regenerative medicines should grow from $4.4 billion in 2019 to reach $11.5 billion by 2024 at a CAGR of 21.3% for the period of 2019-2024.

Report Scope:

The scope of this report is broad and covers various type of product available in the stem cell and regenerative medicines market and potential application sectors across various industries. The current report offers a detailed analysis of the stem cell and regenerative medicines market.

The report highlights the current and future market potential of stem cell and regenerative medicines and provides a detailed analysis of the competitive environment, recent development, merger and acquisition, drivers, restraints, and technology background in the market. The report also covers market projections through 2024.

The report details market shares of stem cell and regenerative medicines based on products, application, and geography. Based on product the market is segmented into therapeutic products, cell banking, tools and reagents. The therapeutics products segments include cell therapy, tissue engineering and gene therapy. By application, the market is segmented into oncology, cardiovascular disorders, dermatology, orthopedic applications, central nervous system disorders, diabetes, others

The market is segmented by geography into the following regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. The report presents detailed analyses of major countries such as the U.S., Canada, Mexico, Germany, the U.K. France, Japan, China and India. For market estimates, data is provided for 2018 as the base year, with forecasts for 2019 through 2024. Estimated values are based on product manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Report Includes:

  • 28 data tables
  • An overview of global markets for stem cell and regenerative medicines
  • Analyses of global market trends, with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Details of historic background and description of embryonic and adult stem cells
  • Information on stem cell banking and stem cell research
  • A look at the growing research & development activities in regenerative medicine
  • Coverage of ethical issues in stem cell research & regulatory constraints on biopharmaceuticals
  • Comprehensive company profiles of key players in the market, including Aldagen Inc., Caladrius Biosciences Inc., Daiichi Sankyo Co. Ltd., Gamida Cell Ltd. And Novartis AG

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Market and Technology Background

  • Overview: Cells
  • Overview: Stem Cell
  • Embryonic Stem Cell (ES)
    • Growth and Identification of Embryonic Stem Cells
    • Stimulating Embryonic Stem Cells to Differentiate
  • Adult Stem Cell
  • Mesenchymal Stem Cells
  • Hematopoietic Stem Cells
  • Neural Stem Cell
  • Endothelial Progenitor Cell
  • Epithelial Stem Cell
  • Very Small Embryonic-Like Cell
  • Cord Blood Stem Cell
  • Induced Pluripotent Stem Cells
    • Evolution of Induced Pluripotent Stem Cell Research
    • Advantages
    • Disadvantages
  • Cellular Reprogramming in Stem Cells
  • Human Parthenogenetic Stem Cells
  • Limitations in Stem Cell and Regenerative Therapy
  • Cancer Stem Cells
  • Historic Background of Stem Biology
  • Stem Cell Research
    • Stem Cell Research Centers
  • Stem Cell Production
    • Stem Cell Acquisition
    • Characterization and Expansion
    • Maintenance and Storage
    • Stem Cell Production Economics
  • Customized Therapy
  • Overview: Regenerative Medicine

Chapter 4: Market Dynamics

  • Market Drivers
    • Increasing Emphasis on Stem Cell Research
    • Growing Research and Development Activities in Regenerative Medicine
    • Rise in Prevalence of Trauma Emergencies and Chronic Diseases
    • Technological Advancement in Stem Cell Tools and Products
  • Market Restraints
    • Ethical Issues in Stem Cell Research & Regulatory Constraints on Biopharmaceuticals
    • Dearth of Skilled Technicians and Poor Infrastructure for Cell Culture Technology
    • High Treatment Cost and Operational Inefficiency Associated with Stem Cell Research

Chapter 5: Market Breakdown by Product

  • Global Stem Cell and Regenerative Medicines Market, by Product
  • Therapeutic Products
    • Market Size and Forecast
    • Cell Therapies
    • Tissue Engineering
    • Gene Therapy
  • Cell Banking
    • Market Size and Forecast
    • Market Analysis
  • Tools and Reagents
    • Market Size and Forecast
    • Market Analysis

Chapter 6: Market Breakdown by Application

  • Global Stem Cell and Regenerative Medicines Market, by Application
  • Oncology
    • Market Size and Forecast
    • Market Analysis
  • Cardiovascular Disorders
    • Market Size and Forecast
    • Market Analysis
  • Dermatology
    • Market Size and Forecast
    • Market Analysis
  • Orthopedic
    • Market Size and Forecast
    • Market Analysis
  • Central Nervous System Disorders
    • Market Size and Forecast
    • Market Analysis
  • Diabetes
    • Market Size and Forecast
    • Market Analysis
  • Others
    • Market Size and Forecast
    • Market Analysis

Chapter 7: Market Breakdown by Region

  • Global Market for Stem Cell and Regenerative Medicines, by Region
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • South America
  • Middle East and Africa

Chapter 8: Regulatory Scenario

  • Stem Cell Regulation
    • Australia
    • Brazil
    • Canada
    • China
    • France
    • Germany
    • India
    • Ireland
    • Israel
    • Italy
    • Japan
    • South Korea
    • Spain
    • U.K.
    • U.S.
    • European Union

Chapter 9: Patent Analysis

  • Patent Analysis
  • Tissue Engineering and Regeneration Patent
    • Japan Patent Analysis
    • Europe Patent Analysis
    • U.S. Patent Analysis
  • Stem Cell Patents
    • Patentability of Stem Cell Lines
    • Policies by Country

Chapter 10: Competitive Landscape

  • Merger and Acquisitions
    • Merger and Acquisitions in 2019 (Till April 2019)
    • Merger and Acquisitions in 2018
    • Merger and Acquisitions in 2017
  • Partnerships and Collaborations
  • Product Launches

Chapter 11: Company Profiles

  • 3DMATRIX
  • ALDAGEN INC.
  • ARTERIOCYTE
  • ATHERSYS INC.
  • BEIKE BIOTECHNOLOGY CO. LTD.
  • BIOTIME INC.
  • BRAINSTORM CELL THERAPEUTICS INC.
  • BOEHRINGER INGELHEIM GMBH
  • CALADRIUS BIOSCIENCES INC.
  • CAPRICOR INC.
  • CELLERANT THERAPEUTICS INC.
  • CERAPEDICS INC.
  • CELLULAR DYNAMICS INTERNATIONAL
  • CELYAD
  • CRYOLIFE INC.
  • CYTORI THERAPEUTICS INC.
  • DAIICHI SANKYO CO. LTD.
  • EPISTEM LTD.
  • GAMIDA CELL LTD.
  • GILEAD SCIENCES INC.
  • GLOBALSTEM
  • HYBRID ORGAN GMBH
  • INTERNATIONAL STEM CELL CORPORATION
  • JUVENTAS THERAPEUTICS INC.
  • MESOBLAST LTD.
  • NOVARTIS AG
  • NUO THERAPEUTICS INC. (CYTOMEDIX INC.)
  • OCATA
  • ORGANOGENESIS INC. (ADVANCED BIOHEALING)
  • OSIRIS THERAPEUTICS INC.
  • PRIMEGEN BIOTECH LLC
  • RENEURON GROUP
  • STEM CELLS INC.
  • STEMEDICA CELL TECHNOLOGIES INC.
  • STEMINA BIOMARKER DISCOVERY INC.
  • STEMPEUTICS
  • TIGENIX NV (A PART OF TAKEDA PHARMACEUTICAL COMPANY LIMITED)
  • U.S. STEM CELL INC.
  • VERICEL CORPORATION
  • VERISTEM
  • VIACYTE INC.
  • VITRO DIAGNOSTICS INC.
  • WICELL RESEARCH INSTITUTE

Chapter 12: Appendix: Abbreviations

Back to Top